Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Saved in:
| Title: | Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. |
|---|---|
| Authors: | Huang DQ; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore., Ajmera V; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA.; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Tomaszewski C; Department of Emergency Medicine, University of California, San Diego and the El Centro Regional Medical Center, San Diego, CA, USA., LaFree A; Department of Emergency Medicine, University of California, San Diego and the El Centro Regional Medical Center, San Diego, CA, USA., Bettencourt R; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA., Thompson WK; Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA., Smith DM; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.; Veteran Affairs Medical Center, San Diego, CA, USA., Malhotra A; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Mehta RL; Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Tolia V; Department of Emergency Medicine, University of California San Diego, La Jolla, CA, USA., Yin J; Department of Pharmacy, University of California San Diego, La Jolla, CA, USA., Insel PA; Department of Pharmacology, University of California San Diego, La Jolla, CA, USA.; Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, CA, USA., Leachman S; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA., Jung J; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA., Collier S; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Richards L; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA., Woods K; Clinical & Translational Research Institute, University of California, San Diego, La Jolla, CA, USA., Amangurbanova M; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA., Bhatt A; Clinical & Translational Research Institute, University of California, San Diego, La Jolla, CA, USA., Zhang X; Division of Biostatistics and Bioinformatics, Herbert Wertheim School of Public Health, University of California San Diego, San Diego, CA, USA., Penciu OM; Beverly Hospital, Montebello, CA, USA., Zarich S; Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA., Retta T; Department of Internal Medicine, Howard University, Washington, DC, USA., Harkins MS; Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA., Teixeira JP; Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA., Chinnock B; Department of Emergency Medicine, University of California San Francisco-Fresno Medical Education Program, Fresno, CA, USA., Utay NS; Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lake JE; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Loomba R; NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA. roloomba@ucsd.edu.; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. roloomba@ucsd.edu.; Division of Epidemiology, Department of Family Medicine and Public Health, University of California at San Diego, San Diego, CA, USA. roloomba@ucsd.edu. |
| Source: | Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 4805-4816. Date of Electronic Publication: 2023 Aug 24. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-023-02618-7 |
